title: Should we practice stem cell therapy for type 1 diabetes mellitus as precision medicine?
authors.affiliation: Department of Regenerative Medicine and Stem Cell Therapy, G.R. Doshi and K.M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC), Dr. H.L. Trivedi Institute of Transplantation Sciences (ITS), Gujarat, India. Electronic address: umangpaedia@yahoo.co.in.
authors.forename: Umang G
authors.initials: UG
authors.lastname: Thakkar
authors.affiliation: Department of Regenerative Medicine and Stem Cell Therapy, G.R. Doshi and K.M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC), Dr. H.L. Trivedi Institute of Transplantation Sciences (ITS), Gujarat, India; Department of Pathology, Laboratory Medicine, Transfusion Services and Immunohematology, G.R. Doshi and K.M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC), Dr. H.L. Trivedi Institute of Transplantation Sciences (ITS), Gujarat, India.
authors.forename: Aruna V
authors.initials: AV
authors.lastname: Vanikar
authors.affiliation: Department of Regenerative Medicine and Stem Cell Therapy, G.R. Doshi and K.M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC), Dr. H.L. Trivedi Institute of Transplantation Sciences (ITS), Gujarat, India; Nephrology and Transplantation Medicine, G.R. Doshi and K.M. Mehta Institute of Kidney Diseases & Research Centre, Dr. H.L. Trivedi Institute of Transplantation Sciences (ITS), Gujarat, India.
authors.forename: Hargovind L
authors.initials: HL
authors.lastname: Trivedi
keywords: Type 1 diabetes mellitus; precision medicine; stem cell therapy